 Vaginally administered estrogens are estrogens that are delivered by intravaginal administration, thereby exerting their effects mainly in the nearby tissue, with more limited systemic effects compared to orally administered estrogens. When used for menopausal hormone replacement therapy, vaginally administered estrogens are intended to decrease the uncomfortable effects on the vagina, vulva and urethra that are caused by the decrease in estrogen production in the body after menopause, such as: 
